Zika Virus Culture
We inoculated samples onto subconfluent Vero cells in 25 cm 2 culture flasks and maintained them in Dulbecco's modified Eagle medium (DMEM) supplemented with 2.5% fetal bovine serum (FBS). We inspected the cells visually every day for the presence of cytopathic effect (CPE). The culture medium of the 25 cm 2 flask presenting CPE was centrifuged at 1000 rpm for 5 minutes to pellet detached cells and we used the supernatant to inoculate new Vero cells. The supernatant of this cell culture presented a similar CPE and tested positive for Zika virus by real-time RT-PCR.
Immunohistochemical Testing
Immunohistochemical analysis was performed at the US Centers for Disease Control and manufacturer's instructions (qGenomics). We analyzed this array using a scanner (Agilent G2565CA Microarray Scanner System, Agilent Technologies, Santa Clara, CA, USA). We quantified and analyzed the captured images using Cytogenomics software (Agilent Technologies).
Diagnostics to Rule Out Other Maternal Infections
According to protocols for prenatal care, and as routinely performed for all pregnant women in the first trimester, the patient was screened for rubella and toxoplasma (she showed previous immunity to both infections), syphilis, HIV, and hepatitis B (she showed negative results). To rule out other maternal infections, residues from curettage were tested and showed negative results by RT-PCR for herpes simplex virus (HSV) type 1 and type 2. Endocervix samples were collected 31 days after surgical evacuation and tested negative for Zika virus by
RT-PCR assay, as well as for Chlamydia trachomatis, Neisseria gonorrhoeae, and HSV 1 and 2.
